Health Sciences. He is Director of the University of Washington Occupational and Environmental Medicine Clinic at Harborview Medical Center in Seattle. Dr. Firestone’s research involves chemical exposures and their interactions with individual genetic susceptibility in neurological disease, with a special focus on Parkinson’s disease. His clinical specialty is in occupational neurotoxicology. Dr. Firestone previously served on the committee for Veterans and Agent Orange: Update 2004.
Peter H. Gann, M.D., Sc.D., is a Professor and Director of Pathology Research at the University of Illinois at Chicago. A physician-epidemiologist by training, his research work focuses on the causes of breast and prostate cancer, with particular emphasis on the development and application of novel biological markers. His interest in biological markers actually originates with his service as a Project Director at the National Academy of Sciences in the 1980s. Prior to his current position, Dr. Gann spent 13 years in the Department of Preventive Medicine at Northwestern University Medical School. He received a B.A. degree from Swarthmore College, M.D. and M.S. (epidemiology/biostatistics) degrees from the University of Pennsylvania, and his doctorate in epidemiology from Harvard University. Dr. Gann serves on a number of national and international advisory and peer-review panels in the field of cancer prevention.
Mark S. Goldberg, Ph.D., is Associate Professor in the Department of Medicine, McGill University, Montreal, associate member in the Joint Departments of Epidemiology and Biostatistics and Occupational Health, the Department of Oncology, and Medical Scientist, Royal Victoria Hospital, McGill University Health Centre. Dr. Goldberg is an occupational and environmental epidemiologist and holds an Investigator Award from the Canadian Institute for Health Research. His current research interests include the investigation of occupational and environmental risk factors for breast cancer and the health effects associated with exposures to ambient air pollution. In addition to being a member of grant review panels, Dr. Goldberg is also a member of Health Canada’s Science Advisory Board. He has served on the committee for Disposition of the Air Force Health Study and the Division of Earth and Life Sciences committee for Assessing the Human Health Risks of Trichloroethylene: Key Scientific Issues.
Claudia Hopenhayn, Ph.D., is an Associate Professor in the Department of Epidemiology at the University of Kentucky, College of Public Health. Her primary research interests have focused on cancer and reproductive outcomes, within the context of environmental and occupational epidemiology and cancer control. Dr. Hopenhayn’s expertise combines toxicology, biomarkers of exposure and effect, statistics, risk factors, and assessment of intervention, within a framework of epidemiology and multidisciplinary collaborations, both in the United States